Beta‐Blocker Use Is Associated With Impaired Left Atrial Function in Hypertension
暂无分享,去创建一个
Timothy S. Phan | M. Sardana | S. Akers | J. Chirinos | A. Syed | Z. Hashmath | Swapna Varakantam | M. R. Koppula | Uzma Kewan | Zoubair Ahmed | Ravikantha Chandamuri | Ejaz Shah | Ryan Gorz | Zeba Hashmath
[1] Juan L. Reutter,et al. TriAL , 2018, ACM Trans. Database Syst..
[2] C. Wiysonge,et al. Beta‐blockers for hypertension , 2017, The Cochrane database of systematic reviews.
[3] P. Messner-Pellenc,et al. Hypertensive patients with left ventricular hypertrophy have global left atrial dysfunction and impaired atrio-ventricular coupling , 2016, Journal of hypertension.
[4] R. Poręba,et al. Arterial–atrial coupling in untreated hypertension , 2015, Blood pressure.
[5] D. Bluemke,et al. Multi-ethnic study of atherosclerosis: association between left atrial function using tissue tracking from cine MR imaging and myocardial fibrosis. , 2014, Radiology.
[6] B. Hoit. Left atrial size and function: role in prognosis. , 2014, Journal of the American College of Cardiology.
[7] C. Ayers,et al. Left atrial structure and function and clinical outcomes in the general population. , 2013, European heart journal.
[8] R. Kwong,et al. Strong cardiovascular prognostic implication of quantitative left atrial contractile function assessed by cardiac magnetic resonance imaging in patients with chronic hypertension , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[9] H. Miyoshi,et al. Early detection of abnormal left atrial-left ventricular-arterial coupling in preclinical patients with cardiovascular risk factors: evaluation by two-dimensional speckle-tracking echocardiography. , 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[10] R. Kronmal,et al. Left Ventricular Mass: Allometric Scaling, Normative Values, Effect of Obesity, and Prognostic Performance , 2010, Hypertension.
[11] J. Sanderson,et al. Reduced left atrial function on exercise in patients with heart failure and normal ejection fraction , 2010, Heart.
[12] J. Butler,et al. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. , 2009, Journal of the American College of Cardiology.
[13] D. Ross,et al. Impact of Mild Hypertension on Left Atrial Size and Function , 2009, Circulation. Cardiovascular imaging.
[14] R. Devereux,et al. Left Atrial Size and Risk of Major Cardiovascular Events During Antihypertensive Treatment: Losartan Intervention for Endpoint Reduction in Hypertension Trial , 2007, Hypertension.
[15] I. Kallikazaros,et al. The interplay between haemodynamic load, brain natriuretic peptide and left atrial size in the early stages of essential hypertension , 2006, Journal of hypertension.
[16] Alice Stanton,et al. Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes: Principal Results of the Conduit Artery Function Evaluation (CAFE) Study , 2006, Circulation.
[17] M. Nieminen,et al. Pulse Pressure and Effects of Losartan or Atenolol in Patients With Hypertension and Left Ventricular Hypertrophy , 2005, Hypertension.
[18] M. Nieminen,et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. , 2005, Journal of the American College of Cardiology.
[19] M. Nieminen,et al. Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial , 2004, Circulation.
[20] M. Nieminen,et al. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. , 2002, JAMA.
[21] M. Michel,et al. Adrenergic and muscarinic receptors in the human heart. , 1999, Pharmacological reviews.
[22] S. Chemtob,et al. Inverse agonist activities of β‐adrenoceptor antagonists in rat myocardium , 1999 .
[23] L. Opie,et al. Betablockers for hypertension , 1998 .
[24] R B D'Agostino,et al. Left atrial size and the risk of stroke and death. The Framingham Heart Study. , 1995, Circulation.
[25] A. Redheuil,et al. Mechanisms of Diastolic Dysfunction in Cardiovascular Disease Left atrial aging : a cardiac magnetic resonance feature-tracking study , 2016 .
[26] W. Elliott. Relation of Beta-Blocker-Induced Heart Rate Lowering and Cardioprotection in Hypertension , 2009 .